Affiliation:
1. Friedrich Miescher Institute, Basel, Switzerland
Abstract
ABSTRACT
Expression of genes of the plasminogen activator (PA) system declines at the G
0
/G
1
-S-phase boundary of the cell cycle. We found that overexpression of E2F1-3, which acts mainly in late G
1
, inhibits promoter activity and endogenous expression of the urokinase-type PA (uPA) and PA inhibitor 1 (PAI-1) genes. This effect is dose dependent and conserved in evolution. Mutation analysis indicated that both the DNA-binding and transactivation domains of E2F1 are necessary for this regulation. Interestingly, an E2F1 mutant lacking the pRB-binding region strongly repressed the uPA and PAI-1 promoters. An E2F-mediated negative effect was also observed in pRB and p107/p130 knockout cell lines. This is the first report that E2F can act as a repressor independently of pocket proteins. Mutation of AP-1 elements in the uPA promoter abrogated E2F-mediated transcriptional inhibition, suggesting the involvement of AP-1 in this regulation. Results shown here identify E2F as an important component of transcriptional control of the PA system and thus provide new insights into mechanisms of cellular proliferation.
Publisher
American Society for Microbiology
Subject
Cell Biology,Molecular Biology
Reference68 articles.
1. The urokinase-type plasminogen activator system in cancer metastasis: a review;Andreasen P. A.;Int. J. Cancer,1997
2. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1;Angel P.;Cell,1988
3. Recruitment of p300/CBP in p53-dependent signal pathways;Avantaggiati M. L.;Cell,1997
4. CBP-induced stimulation of c-Fos activity is abrogated by E1A;Bannister A. J.;EMBO J.,1995
5. Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro;Bannister A. J.;Oncogene,1995
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献